The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE postpones vehicle licensing limit for residents
UAE Government Annual Meetings key to reviewing national priorities
New pedestrian bridge links Dubai Mall Metro Station and Coca-Cola Arena
High-achieving Union teams honoured at UAE Government Annual Meetings
Al Gergawi: UAE accelerates development with over AED 4 trillion in projects
Abu Dhabi launches lifestyle programme to help citizens get healthier
5 Esaad cards up for grabs in Dubai Police's 5-week traffic contest
Nominations open for Aster Guardians Global Nursing Award
Dubai Police warns against using phones while driving after four-way crash
RTA opens 1,650-metre Al Khaleej Street Tunnel
Sharjah Ruler allocates AED 4.5 million to stock libraries with book fair collection
UAE expresses solidarity with Egypt over train collision
UAE President sends Diwali greetings in special message
UAE National Guard rescues 22 from cargo ship fire in Sea of Oman
Sheikh Abdullah congratulates Venezuelan FM on appointment
UAE President visits an Emirati family at Abu Dhabi home
UAE strongly condemns shooting incident in Poland's Krakow
UAE foils attempt to smuggle 200,000 Captagon pills, dismantles drug network
